Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Repaglinide 135062-02-1

Repaglinide 135062-02-1

Inquiry
  Post Date: May 07,2019
  Expiry Date: Nov 03,2019
  Detailed Description: Cas No. :135062-02-1;108157-52-4 Repaglinide is an antidiabetic drug in the class of medications known as meglitinides. It is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus.

  CAS Registry Number:

135062-02-1;108157-52-4
  Synonyms: ;4-Ethoxycarbonyl-3-ethoxy phenyl acetic acid;(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid;2-ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;
  Molecular Formula: C27H36N2O4
  Molecular Weight: 452.5857
  Molecular Structure: 135062-02-1;108157-52-4 Repaglinide

  Company: Shanghai Neopharm Co., Ltd.     [ China ]          
  Contact: Carol Zhu
  Tel: 021-58826758
  Fax: 021-58827258
  Email: sales@neopharm.com.cn
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.